Search Results - "Sidelmann, J. J."

Energy availability and the female athlete triad in elite endurance athletes by Melin, A., Tornberg, Å. B, Skouby, S., Møller, S. S., Sundgot-Borgen, J., Faber, J., Sidelmann, J. J., Aziz, M., Sjödin, A.

“…The female athlete triad (Triad), links low energy availability (EA), with menstrual dysfunction (MD), and impaired bone health. The aims of this study were to…”
Get full text

Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D by MARCKMANN, Peter, AGERSKOV, Hanne, THINESHKUMAR, Sasikala, BLADBJERG, Else-Marie, SIDELMANN, Johannes J, JESPERSEN, Jørgen, NYBO, Mads, RASMUSSEN, Lars M, HANSEN, Ditte, SCHOLZE, Alexandra

“…Hypovitaminosis D is common in chronic kidney disease (CKD). Effects of 25-hydroxyvitamin D replenishment in CKD are not well described. An 8-week randomized,…”
Get full text

Calibrated kallikrein generation in human plasma by Biltoft, D., Sidelmann, J.J., Olsen, L.F., Palarasah, Y., Gram, J.

“…The physiological role of the contact system remains inconclusive. No obvious clinical complications have been observed for factor XII (FXII), prekallikrein…”
Get full text

Revisiting the Phadia/EliA cut-off values for anticardiolipin and anti-β2-glycoprotein I antibodies: a systematic evaluation according to the guidelines by Bor, M V, Jacobsen, I-L Søtang, Gram, J B, Sidelmann, J J

“…Background Phadia/EliA fluorescence enzyme immunoassays are widely used automated assays for anticardiolipin (aCL) and anti-β2-glycoprotein I (aβ2GPI)…”
Get full text

Genome‐wide analysis of genetic determinants of circulating factor VII‐activating protease (FSAP) activity by Olsson, M., Stanne, T. M., Pedersen, A., Lorentzen, E., Kara, E., Martinez‐Palacian, A., Rønnow Sand, N. P., Jacobsen, A. F., Sandset, P. M., Sidelmann, J. J., Engström, G., Melander, O., Kanse, S. M., Jern, C.

“…Summary Essentials Knowledge of genetic regulators of plasma factor VII activating protease (FSAP) levels is limited. We performed a genome‐wide analysis of…”
Get full text

Intraoperative Blood Loss During Orthognathic Surgery Is Predicted by Thromboelastography by Madsen, Daniel E., MSc, Ingerslev, Janne, DDS, Sidelmann, Johannes J., PhD, Thorn, Jens J., DDS, PhD, Gram, Jørgen, MD, DSc

“…Purpose The aim of this prospective study was to evaluate the predictive value of the viscoelastic properties of whole blood samples collected preoperatively…”
Get full text

Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes by Scholze, Alexandra, Bladbjerg, Else-Marie, Sidelmann, Johannes J, Diederichsen, Axel C P, Mickley, Hans, Nybo, Mads, Argraves, W Scott, Marckmann, Peter, Rasmussen, Lars M

“…Fibulin-1 is one of a few extracellular matrix proteins present in blood in high concentrations. We aimed to define the relationship between plasma fibulin-1…”
Get full text

Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease by Trink, Jackie, Li, Renzhong, Palarasah, Yaseelan, Troyanov, Stéphan, Andersen, Thomas E., Sidelmann, Johannes J., Inman, Mark D., Pizzo, Salvatore V., Gao, Bo, Krepinsky, Joan C.

“…Diabetic kidney disease (DKD) is caused by the overproduction of extracellular matrix proteins (ECM) by glomerular mesangial cells (MCs). We previously showed…”
Get full text

Sex difference in clot lysability and association to coronary artery calcification by Ramanathan, Ramshanker, Sand, Niels Peter R, Sidelmann, Johannes J, Nørgaard, Bjarne L, Gram, Jørgen B

“…Incidence and prevalence of cardiovascular disease (CVD) differ between sexes, and women experience CVD later than men. Changes in fibrin clot lysability are…”
Get full text

Fibrin clot formation and lysis: basic mechanisms by Sidelmann, J J, Gram, J, Jespersen, J, Kluft, C

“…The hemostatic balance, introduced more than 40 years ago, addresses the components and reactions involved in fibrin turnover. Fibrin is placed in the core of…”
Get more information

Fibrin clot structure in patients with end-stage renal disease by Sjøland, Jonas A, Sidelmann, Johannes J, Brabrand, Mikkel, Pedersen, Robert S, Pedersen, Jørgen H, Esbensen, Kim, Standeven, Kristina F, Ariëns, Robert A S, Gram, Jørgen

“…Fibrin clots with reduced permeability, increased clot stiffness and reduced fibrinolysis susceptibility may predispose to cardiovascular disease (CVD). Little…”
Get more information

Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women by Sidelmann, J. J., Skouby, S. O., Vitzthum, F., Schwarz, H., Jespersen, J.

“…Objectives Current reviews indicate that hormone therapy (HT) has a protective role in coronary heart disease (CHD) in younger postmenopausal women, whereas HT…”
Get full text

Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo by Sidelmann, Johannes J, Skouby, Sven O, Kluft, Cornelis, Winkler, Ulrich, Vitzthum, Frank, Schwarz, Herbert, Gram, Jørgen, Jespersen, Jørgen

“…Abstract Oral contraceptive (OC) use influences the hemostatic system significantly and is a risk factor for development of cardiovascular disease. Factor…”
Get full text

Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives by Glintborg, Dorte, Sidelmann, Johannes J, Altinok, Magda Lambaa, Mumm, Hanne, Andersen, Marianne

“…Polycystic ovary syndrome (PCOS) is associated with risk factors for cardiovascular disease (CVD) which may be modified by the use of metformin and oral…”
Get full text

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study

“…We investigated the effects of ethinylestradiol dose (50, 30 and 20 μg) and progestogen type [desogestrel (DSG), gestodene (GSD), levonorgestrel (LNG) and…”
Get full text

Anabolic Androgenic Steroid Abuse: The Effects on Thrombosis Risk, Coagulation, and Fibrinolysis by Chang, Simon, Münster, Anna-Marie B, Gram, Jørgen, Sidelmann, Johannes J

“…Anabolic androgenic steroid (AAS) abuse surged during the 1980s and is seen in approximately 1 in 20 of all males today. A wide spectrum of AAS compounds and…”
Get more information

Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure by Damiana, Tyrillshall, Damgaard, Dres, Sidelmann, Johannes J., Nielsen, Claus H., de Maat, Moniek P.M., Münster, Anna-Marie B., Palarasah, Yaseelan

“…•Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.•Citrullination of fibrinogen by peptidylarginine deiminase 2…”
Get full text

Orthognathic Surgery-Induced Fibrinolytic Shutdown Is Amplified by Tranexamic Acid by Sidelmann, Johannes J., Gram, Jørgen B., Godtfredsen, Anne C.M., Thorn, Jens J., Ingerslev, Janne, Pinholt, Else M.

“…Little is known of the systemic effects of oral and maxillofacial surgery on the hemostatic balance, including the biochemical effects of tranexamic acid…”
Get full text

Effect of remote ischemic preconditioning on fibrin formation and metabolism in patients undergoing hip fracture surgery: a randomized clinical trial by Wahlstrøm, Kirsten L., Ekeloef, Sarah, Sidelmann, Johannes J., Gögenur, Ismail, Münster, Anna-Marie B.

“…Remote ischemic preconditioning (RIPC) prior to surgery has recently been shown to reduce the risk of myocardial injury and myocardial infarction after hip…”
Get full text

Assessing Safety of Thrombolytic Therapy by Kluft, Cornelis, Sidelmann, Johannes J, Gram, Jørgen B

“…Thrombolytic therapy involves thrombolytic agents administered to patients suffering from venous or arterial thrombosis. The therapy induces systemic effects…”
Get more information